Determining the role of type I interferons in ultraviolet-B light induced keratinocyte death
确定 I 型干扰素在紫外线 B 光诱导的角质形成细胞死亡中的作用
基本信息
- 批准号:10456175
- 负责人:
- 金额:$ 3.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectApoptosisApoptoticAutoimmune DiseasesAutomobile DrivingCASP8 geneCRISPR/Cas technologyCXCL10 geneCXCL11 geneCaspaseCaspase InhibitorCategoriesCause of DeathCell DeathCell ProliferationCellsCessation of lifeChronicClinicalCommunicationCutaneousCutaneous InvolvementCutaneous Lupus ErythematosusDataData AnalysesDevelopmentDiseaseEconomic BurdenEnsureExperimental DesignsExposure toFemale of child bearing ageFlareFutureGenerationsGenesGeneticGenetic TranscriptionGenetically Engineered MouseGoalsHuman Cell LineIRF1 geneImmune systemIn VitroInflammationInflammatoryInterferon Type IInterferon-alphaInterferonsInterleukin-15Knock-outKnowledgeLaboratoriesLeadLesionLightLinkLupusLupus ErythematosusMeasuresMediatingMentorsMichiganMutateNatural Killer Cell toxicityNatural Killer CellsOrganPainPathogenesisPathway interactionsPatientsPhotosensitivityPlayPopulationPreventionProductionQuality of lifeReactive Oxygen SpeciesRegulationResearchResearch TrainingResourcesRoleSignal TransductionSkinSmall Interfering RNAStressSunlightSunscreening AgentsSystemic Lupus ErythematosusSystemic diseaseTestingThe SunUV Radiation ExposureUV inducedUVB inducedUltraviolet B RadiationUltraviolet RaysUniversitiesUp-RegulationVirus DiseasesWorkXAF1 genebasecell killingcell motilitychemokinecytokinecytotoxiccytotoxicityexperienceexperimental studyin vivoirradiationkeratinocyteknock-downlupus cutaneousnovel therapeuticsoverexpressionpreventpro-apoptotic proteinrecruitresponseskillsskin disordertherapeutic targettranscription factortumorigenesisultravioletx-linked inhibitor of apoptosis protein
项目摘要
PROJECT SUMMARY/ABSTRACT
Lupus erythematosus is a chronic, debilitating autoimmune disease that disproportionately affects women of
childbearing age and has been found to be among the leadings causes of death in this population. The systemic
form of the disease, systemic lupus erythematosus (SLE), has heterogeneous clinical manifestations that can
affect nearly all major organs of the body. When there is skin involvement, the disease is grouped under the
category of cutaneous lupus erythematosus (CLE). CLE can occur on its own or in combination with systemic
disease with up to 70% of SLE patients experiencing cutaneous involvement. Both SLE and CLE are
characterized by increased sensitivity to ultraviolet (UV) light. UV light can trigger cutaneous and systemic
disease flares that severely diminish patient quality of life and carry significant economic burdens. As the
mechanisms driving these responses are not understood, few treatment options exist with prevention largely
based on sun avoidance and sunscreen use. Type I interferons (IFNs), a group of cytokines generally produced
in response to viral infection, are chronically overexpressed in lupus patients with circulating levels correlating
with cutaneous disease activity. Type I IFNs regulate expression of several genes that may play a role in
photosensitivity including pro-apoptotic Xaf1 and chemokines that promote natural killer (NK) cell recruitment
and activation. The Kahlenberg laboratory previously observed that type I interferons (IFNs) are increased at
baseline in SLE keratinocytes (KCs) and promote cell death after UV exposure. However, the specific pathways
regulated by type I IFNs that enhance UV-driven KC death are not known. This proposal will test the hypothesis
that chronic overexpression of type I IFNs in lupus skin primes keratinocytes for increased UVB-induced
extrinsic apoptosis through upregulated XAF1 expression and enhanced recruitment and activation of
cytotoxic NK cells. This hypothesis will be tested through three specific aims: (1) Examine activation of extrinsic
vs. intrinsic apoptosis in type I IFN-primed skin following UVB exposure, (2) Determine the role of XAF1 in type
I IFN-driven KC apoptosis, and (3) Identify the role of NK cells in type I IFN-driven KC apoptosis. To accomplish
these specific aims, human cell lines and genetically engineered mouse models will be used to perform in vitro
and in vivo experiments investigating cell signaling and genetic regulation of type I IFN-primed KCs exposed to
UV light and to determine how this influences NK cells that are recruited into the skin. The results from these
studies will establish the impacts of type I IFN overproduction in lupus skin in the context of photosensitivity with
the overall future goal of identifying targets for new treatment options for patients whose disease is flared by the
sun. This project will serve as a crucial mechanism through which the applicant will further expand her core skills
in experimental design and data analysis, professional development, and scientific communication. The ample
resources available at the University of Michigan together with experienced mentors and collaborators will ensure
the applicant is able to successfully complete the proposed research and training plans.
项目概要/摘要
红斑狼疮是一种慢性、使人衰弱的自身免疫性疾病,对女性的影响尤为严重
育龄期已被发现是该人群死亡的主要原因之一。系统性的
该疾病的一种形式,系统性红斑狼疮 (SLE),具有异质性的临床表现,
几乎影响身体所有主要器官。当有皮肤受累时,该疾病分为以下几类:
皮肤红斑狼疮(CLE)的类别。 CLE 可以单独发生,也可以与全身系统联合发生
高达 70% 的 SLE 患者出现皮肤受累。 SLE 和 CLE 都是
其特点是对紫外线 (UV) 光的敏感性增加。紫外线可以触发皮肤和全身
疾病爆发严重降低患者的生活质量并带来沉重的经济负担。作为
驱动这些反应的机制尚不清楚,治疗选择很少,主要是预防
基于避免阳光照射和使用防晒霜。 I 型干扰素 (IFN),通常产生的一组细胞因子
作为对病毒感染的反应,在狼疮患者中长期过度表达,其循环水平与
伴有皮肤疾病活动。 I 型干扰素调节多个基因的表达,这些基因可能在
光敏性,包括促凋亡 Xaf1 和促进自然杀伤 (NK) 细胞募集的趋化因子
和激活。 Kahlenberg 实验室此前观察到,I 型干扰素 (IFN) 在
系统性红斑狼疮 (SLE) 角质形成细胞 (KC) 的基线,并在紫外线照射后促进细胞死亡。但具体途径
受 I 型 IFN 调节而增强 UV 驱动的 KC 死亡的机制尚不清楚。该提案将检验假设
狼疮皮肤中 I 型干扰素的长期过度表达会促使角质形成细胞增加 UVB 诱导的影响
通过上调 XAF1 表达并增强招募和激活外源性细胞凋亡
细胞毒性 NK 细胞。该假设将通过三个具体目标进行检验:(1)检查外在因素的激活
与 UVB 暴露后 I 型 IFN 引发的皮肤中的内在细胞凋亡相比,(2) 确定 XAF1 在类型中的作用
I IFN 驱动的 KC 细胞凋亡,以及 (3) 鉴定 NK 细胞在 I 型 IFN 驱动的 KC 细胞凋亡中的作用。为了完成
这些具体目标,人类细胞系和基因工程小鼠模型将用于在体外进行
和体内实验研究暴露于 I 型 IFN 引发的 KC 的细胞信号传导和遗传调控
紫外线并确定其如何影响招募到皮肤中的 NK 细胞。这些结果
研究将确定 I 型干扰素过量产生对狼疮皮肤光敏性的影响
未来的总体目标是为患有疾病的患者确定新的治疗方案目标
太阳。该项目将成为申请人进一步扩展其核心技能的重要机制
实验设计和数据分析、专业发展和科学交流。充足的
密歇根大学的可用资源以及经验丰富的导师和合作者将确保
申请人能够成功完成拟议的研究和培训计划。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation.
- DOI:10.1016/j.jid.2021.05.029
- 发表时间:2022-01
- 期刊:
- 影响因子:0
- 作者:Gharaee-Kermani M;Estadt SN;Tsoi LC;Wolf-Fortune SJ;Liu J;Xing X;Theros J;Reed TJ;Lowe L;Gruszka D;Ward NL;Gudjonsson JE;Kahlenberg JM
- 通讯作者:Kahlenberg JM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shannon Loftus其他文献
Shannon Loftus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shannon Loftus', 18)}}的其他基金
Determining the role of type I interferons in ultraviolet-B light induced keratinocyte death
确定 I 型干扰素在紫外线 B 光诱导的角质形成细胞死亡中的作用
- 批准号:
10254276 - 财政年份:2020
- 资助金额:
$ 3.92万 - 项目类别:
Determining the role of type I interferons in ultraviolet-B light induced keratinocyte death
确定 I 型干扰素在紫外线 B 光诱导的角质形成细胞死亡中的作用
- 批准号:
10065202 - 财政年份:2020
- 资助金额:
$ 3.92万 - 项目类别:
相似国自然基金
VNN1通过内质网非折叠蛋白应激介导单核巨噬细胞凋亡影响创伤患者脓毒症发生的机制研究
- 批准号:82372549
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
EHMT1通过CBX4/MLKL轴调控心肌细胞坏死性凋亡影响心肌缺血再灌注损伤的机制研究
- 批准号:82370288
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
MLCK1介导细胞凋亡和自噬影响炎症性肠病进展
- 批准号:82370568
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
- 批准号:32372397
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
应激颗粒自噬对低氧诱导猪卵泡颗粒细胞凋亡的影响及机制研究
- 批准号:32302741
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 3.92万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
The transcriptional control of vascular calcification in disease
疾病中血管钙化的转录控制
- 批准号:
10647475 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别: